San Antonio · San Francisco · Seattle · Silicon Valley · St. Louis · Tampa Bay ... The biotech discontinued two Phase 1/2 trials of its lead cancer drug ...
News
- Bicycle Therapeutics cuts 30% of workforce as it winds down lead cancer drug - Boston ...
- New Case Study: bioAffinity Technologies' CyPath® Lung Provides Actionable Results and ...
SAN ANTONIO--(BUSINESS WIRE)-- bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing noninvasive diagnostics for ...
- KENS 5: UT Health San Antonio announces new 'Center for Excellence' in diabetes
KENS 5: UT Health San Antonio announces new 'Center for Excellence' in diabetes ... biomedical sciences and public health that are leading change ...
- Agenus: Q4 Earnings Snapshot | kens5.com
The biotechnology company posted revenue of $34.2 million in the period. ... Download the San Antonio News from KENS 5 App. Download on the App Store ...
- UT Health San Antonio launches diabetes center to combat the disease through advanced research
Bioscience-Medicine Top StoriesTPRUT Health San Antoniodiabetes · Facebook · Twitter · LinkedIn · Email · Kory Cook · See stories by Kory Cook. Latest ...